Verily Life Sciences
Overview
Verily, an Alphabet subsidiary, develops precision health tools and research platforms that integrate genomics, wearables, and real-world data to accelerate disease research and clinical trials.
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Category
🧬 Research Tools | Clinical Diagnostics
Location
South San Francisco, CA, USA
Funding
Alphabet subsidiary ($1B+ invested)
Website
www.verily.comListed
2026-06-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →